Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation

Fu,Xiaoyu; Song,Xiaoling; Li,Yanyan; Tan,Deming; Liu,Guozhen

doi:10.3892/mmr.2015.4545

January-2016 Volume 13 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-2016 Volume 13 Issue 1

Full Size Image

Article

Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation

Authors:
- Xiaoyu Fu
- Xiaoling Song
- Yanyan Li
- Deming Tan
- Guozhen Liu
View Affiliations / Copyright

Affiliations: Department of Infectious Disease, Key Laboratory of Viral Hepatitis of Hunan, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Infectious Disease, East of People's Hospital, Linyi, Shandong 276034, P.R. China, Department of Infectious Disease, The Eighth People's Hospital of Nanchang, Nanchang, Jiangxi 330008, P.R. China
Pages: 301-308
|
Published online on: November 11, 2015

https://doi.org/10.3892/mmr.2015.4545
Expand metrics +

Abstract

The aim of the present study was to investigate the effect of hepatitis B virus X protein (HBx) on the expression of DNA methyltransferase (DNMT)3A/3B and suppressors of cytokine signaling‑1 (SOCS‑1), as well as promoter CpG island methylation of the SOCS‑1 gene. Stable hepatocyte cell lines expressing the HBx gene (pcDNA‑X/QSG7701) or an empty gene (pcDNA3.0/QSG7701) were established. Reverse transcription quantitative polymerase chain reaction (PCR) was used to detect the mRNA expression levels of DNMT3A/3B and SOCS‑1. Immunohistochemistry was used to detect the protein expression of DNMT3A/3B. Methylation‑specific PCR (MSP) was used to detect the methylation status of the SOCS‑1 gene promoter. The mRNA and protein expression levels of DNMT3A/3B were significantly higher in the pcDNA‑X/QSG7701‑transfected cells, compared with those in the pcDNA3.0/QSG7701 or non‑transfected QSG7701 cells (P<0.05), whereas the relative mRNA expression of SOCS‑1 was significantly lower in the pcDNA‑X/QSG7701 cells compared with the pcDNA3.0/QSG7701 and non‑transfected QSG7701 cells (F=19.6; P<0.05). Western blot analysis showed that the protein expression of SOCS‑1 was significantly lower in the pcDNA‑X/QSG7701 cells, compared with the pcDNA3.0/QSG7701 or non‑transfected QSG7701 cells (F=19.4; P<0.05). The results of the MSP analysis showed that SOCS‑1 promoter region methylation was present only in the pcDNA‑X/QSG7701 cells. The HBV‑X gene upregulated the mRNA and protein expression levels of DNMT3A/3B, downregulated the expression of SOCS‑1 and increased SOCS‑1 gene promoter CpG island methylation. This may provide a potential explanation of the mechanism underlying HBx-associated hepatocellular carcinoma.

View Figures

View References

1	Nguyen VT, Law MG and Dore GJ: Hepatitis B-related hepato-cellular carcinoma: Epidemiological characteristics and disease burden. J Viral Hepat. 16:453–463. 2009. View Article : Google Scholar : PubMed/NCBI
2	Rabe C, Cheng B and Caselmann WH: Molecular mechanisms of hepatitis B virus-associated liver cancer. Dig Dis. 19:279–282. 2001. View Article : Google Scholar
3	Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC and Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 28:29–35. 2001. View Article : Google Scholar : PubMed/NCBI
4	Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ and Lee YI: Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology. 132:1476–1494. 2007. View Article : Google Scholar : PubMed/NCBI
5	Wang ZG and Wu JX: DNA methyltransferase: Classification, research progress. Yi Chuan. 31:903–912. 2009.In Chinese. View Article : Google Scholar : PubMed/NCBI
6	Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res. 61:7959–7963. 2001.PubMed/NCBI
7	Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G, Molina FJ, Calasanz MJ, Prosper F, Heiniger A and Torres A: Promoter hypermethylation of cancer-related genes: A strong independent prognostic factor in acute lymphoblastic leukemia. Blood. 104:2492–2498. 2004. View Article : Google Scholar : PubMed/NCBI
8	Chen L, Zhu Z, Sun X, Dong XY, Wei J, Gu F, Sun YL, Zhou J, Dong JT and Fu L: Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involvespromoter methylation and associates with metastasis. Breast Cancer Res Treat. 116:471–478. 2009. View Article : Google Scholar
9	Mendez N, Orenes-Piñero E, Gaspar M, Fierro M, Ecke T, Gil M, Palou J, et al: Discovery of the methylation of the metastasis suppressor gene, KISS-1, in bladder cancer. J Urology. 181:3742009. View Article : Google Scholar
10	Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S and Zhu J: Methylation profiling of twenty promoter- CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2:292002. View Article : Google Scholar
11	Murakami S: Hepatitis B Virus X Protein: Structure, function and biology. Intervirology. 42:81–99. 1999. View Article : Google Scholar : PubMed/NCBI
12	Zhao H, Liu KG, Shang HL, et al: The correlation of HBx and VEGF expression with angiogenesis and metastasis in HBV related hepatocelular carcinoma. Chin Hepatol. 1:15–18. 2010.
13	Li W, Miao X, Qi Z, Zeng W, Liang J and Liang Z: Hepatitis B virus x protein upregulates HSP90 alpha expression via activation of c-myc in human hepatocarcinoma cell line, HepG2. Virol J. 7:452010. View Article : Google Scholar
14	Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C and Ilangumaran S: SOCS-1 controls liver regeneration by regulating HGF signaling in hepatocytes. J Hepatol. 55:1300–1308. 2011. View Article : Google Scholar : PubMed/NCBI
15	Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G, Li L, Dai N, Si J, Tao Q, Sung JJ and Yu J: Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology. 53:843–853. 2011. View Article : Google Scholar : PubMed/NCBI
16	Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H and Yoshimura A: SOCS1 is a suppressorof liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med. 199:1701–1707. 2004. View Article : Google Scholar : PubMed/NCBI
17	Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu MW, Lee PH, Bernard Weinstein I and Santella RM: Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepato-cellular carcinoma. Cancer Lett. 275:277–284. 2009. View Article : Google Scholar
18	Venkitachalam S, Chueh FY, Leong KF, Pabich S and Yu CL: Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase. Oncol Rep. 25:677–683. 2011.PubMed/NCBI
19	Peng XC, Ma HY and Wang CQ: Aberrant methylation of suppressor of Ccytokine signaling-1 gene in human gastric carcinomas. Journal of Yangtze University (Natural Science Edition). 5:5–8. 2008.
20	Chen NP, Jiang YG, Miao H, et al: Expression and clinical significance of SOSC-1 in human hepatocellular cancer. J Exp Surg. 2:845–847. 2008.
21	Chu PY, Yeh CM, Hsu NC, Chang YS, Chang JG and Yeh KT: Epigenetic alteration of the SOCS-1 gene in hepatocellular carcinoma. Swiss Med Wkly. 140:w130652010.
22	Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H and Yoshimura A: Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol. 31:980–985. 2011. View Article : Google Scholar : PubMed/NCBI
23	Kiran M, Chawla YK and Kaur J: Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Cancer Genet Cytogenet. 195:112–119. 2009. View Article : Google Scholar : PubMed/NCBI
24	Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H and Nakao A: Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer. 97:1260–1265. 2007. View Article : Google Scholar : PubMed/NCBI
25	Ko E, Kim SJ, Joh JW, Park CK, Park J and Kim DH: CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma. Cancer Lett. 271:240–250. 2008. View Article : Google Scholar : PubMed/NCBI
26	Miyoshi H, Fujie H, Shintani Y, Tsutsumi T, Shinzawa S, Makuuchi M, Kokudo N, Matsuura Y, Suzuki T, Miyamura T, et al: Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol. 43:757–763. 2005. View Article : Google Scholar : PubMed/NCBI
27	Su PF, Lee TC, Lin PJ, Lee PH, Jeng YM, Chen CH, Liang JD, Chiou LL, Huang GT and Lee HS: Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int J Cancer. 121:1257–1264. 2007. View Article : Google Scholar : PubMed/NCBI
28	Yan J, Lu Q, Dong J, Li X, Ma K and Cai L: Hepatitis B virus X protein suppresses caveolin-1 expression in hepatocellular carcinoma by regulating DNA methylation. BMC Cancer. 12:3532012. View Article : Google Scholar : PubMed/NCBI
29	Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q and Zhu HG: Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA meth-yltransferases in hepatocarcinogenesis. Exp Mol Pathol. 89:268–275. 2010. View Article : Google Scholar : PubMed/NCBI
30	Liu LM, Luo L, Jing M, et al: HBx in HCC pathogenesis and biological treatment strategies. World J Gastroenterol. 13:432–439. 2005.
31	Zhang YG and Liu BC: Functions of DNA methyltransferase and methylation in tumor generation. Int J Surg. 35:537–540. 2008.
32	Zhang JC, Lu J, Li HP, et al: p16 promoter hypermethylation in the plasma DNA and its possible application in molecular diagnosis of hepatocellular carcinoma. Zhonghua Jian Yan Yi Xue Za Zhi. 29:895–898. 2006.
33	Schagdarsurengin U, Wikens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B and Dammann R: Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene. 22:1866–1871. 2003. View Article : Google Scholar : PubMed/NCBI
34	Yang B, Guo M, Herman JG and Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol. 163:1101–1107. 2003. View Article : Google Scholar : PubMed/NCBI
35	Wang DF, Liu S, Liu QY, et al: The relationship between HBx and methylation status of MATs promoters in hepatocellular carcinoma. J Exp Surg. 28:242–244. 2011.
36	Jung JK, Arora P, Pagano JS and Jang KL: Expression of DNA methytranferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 46/pRb-E2F1 pathway. Cancer Res. 67:5771–5778. 2007. View Article : Google Scholar : PubMed/NCBI
37	Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, Wang KS, Zhang X, Huang J and Han ZG: Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol. 50:377–387. 2009. View Article : Google Scholar